Automated Insulin Delivery (AID) as the Preferred Standard
As of the 2026 ADA Standards of Care, AID systems (Artificial Pancreas) are officially the preferred insulin delivery method over traditional injections or non-automated pumps.
Hierarchy of Care: The guidelines now prioritize AID for adults and children with Type 1, as well as many with Type 2. This removes long-standing barriers such as "C-peptide minimums" or mandatory trial periods on manual injections.
Algorithm Choice: Modern systems like twiist now offer "Algorithm Interoperability," allowing users to choose between embedded versions of community-driven algorithms (like Loop) or industry-standard predictive models (like DBLG2). This personalization empowers users to choose between a "hands-on" or a "fully autonomous" experience.
Sustainability: In late 2025/early 2026, major manufacturers like Insulet expanded nationwide recycling programs for pods, addressing the environmental impact of single-use components in the diabetes device lifecycle.